Bradford Crutchfield 10x Genomics, Inc. (TXG) insider trading activity

TXG Quotes by TradingView

Bradford Crutchfield is Chief Commercial Officer of 10x Genomics, Inc.. Currently has a direct ownership of 97,237 shares of TXG, which is worth approximately $2.15 Million. The most recent transaction as insider was on May 12, 2021, when has been sold 17,000 shares (Class A Common Stock) at a price of $135.73 per share, resulting in proceeds of $2,307,410. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97.2K
0% 3M change
0% 12M change
Total Value Held $2.15 Million

BRADFORD CRUTCHFIELD Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 12 2021
SELL
Open market or private sale
$2,307,410 $135.73 p/Share
17,000 Reduced 32.94%
34,608 Class A Common Stock
May 12 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 24.78%
51,608 Class A Common Stock
Apr 12 2021
SELL
Open market or private sale
$3,166,250 $186.25 p/Share
17,000 Reduced 32.94%
34,608 Class A Common Stock
Apr 12 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 24.78%
51,608 Class A Common Stock
Mar 19 2021
BUY
Grant, award, or other acquisition
-
8,935 Added 17.03%
43,543 Class A Common Stock
Mar 12 2021
SELL
Open market or private sale
$2,670,870 $157.11 p/Share
17,000 Reduced 32.94%
34,608 Class A Common Stock
Mar 12 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 24.78%
51,608 Class A Common Stock
Feb 01 2021
SELL
Open market or private sale
$3,000,160 $176.48 p/Share
17,000 Reduced 32.94%
34,608 Class A Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 24.78%
51,608 Class A Common Stock
Jan 04 2021
SELL
Open market or private sale
$2,385,780 $140.34 p/Share
17,000 Reduced 32.94%
34,608 Class A Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 24.78%
51,608 Class A Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$104,972 $3.12 p/Share
33,645 Added 49.29%
34,608 Class A Common Stock
Dec 01 2020
SELL
Open market or private sale
$2,580,940 $151.82 p/Share
17,000 Reduced 94.64%
963 Class A Common Stock
Dec 01 2020
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 48.62%
17,963 Class A Common Stock
Nov 03 2020
SELL
Open market or private sale
$889,952 $137.0 p/Share
6,496 Reduced 87.09%
963 Class A Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
$7,535 $1.16 p/Share
6,496 Added 46.55%
7,459 Class A Common Stock
Nov 02 2020
SELL
Open market or private sale
$1,441,044 $137.19 p/Share
10,504 Reduced 91.6%
963 Class A Common Stock
Nov 02 2020
BUY
Exercise of conversion of derivative security
$12,185 $1.16 p/Share
10,504 Added 47.81%
11,467 Class A Common Stock
Oct 01 2020
SELL
Open market or private sale
$2,136,050 $125.65 p/Share
17,000 Reduced 94.64%
963 Class A Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 48.62%
17,963 Class A Common Stock
BC

Bradford Crutchfield

Chief Commercial Officer
Pleasanton, CA

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TXG